GlassScriptPhysician profile
Alison Humphrey
NPI 1437470978
$2,107.34
in general payments reported to CMS, 2019-2025
19 companies · $332 in 2025
The $332 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,079 · 2020: $151 · 2021: $105 · 2022: $189 · 2023: $90.89 · 2024: $162 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495 · Education: $89.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.31 |
| Education | $89.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $363.05 | 2021-2025 | Dupixent |
| Glaxosmithkline, LLC. | $315.85 | 2019-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $264.13 | 2019-2025 | Fasenra |
| Genzyme Corporation | $259.88 | 2019-2025 | |
| Pfizer INC. | $163.04 | 2019 | |
| Genentech USA, INC. | $138.46 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $123.78 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $117.99 | 2020 | |
| Kaleo, INC. | $73.64 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $58.02 | 2025 | |
| Phadia US INC. | $44.49 | 2022-2023 | Immunocap |
| Greer Laboratories, INC. | $42.07 | 2022 | |
| Csl Behring | $25.00 | 2019 | |
| Shire North American Group INC | $23.41 | 2019 | |
| Incyte Corporation | $20.84 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $20.09 | 2024 | |
| Optinose US, INC. | $20.02 | 2024 | |
| Alk-Abello, INC | $18.58 | 2023 | Ragwitek, Odactra, Grastek |
| Biocryst US Sales Co., LLC | $15.00 | 2024 | Orladeyo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Humphrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.